[A new peripheral vasodilator prostaglandin E1 in atherosclerosis of lower limb vessels and Raynaud disease].
作者信息
Kirichenko A A, Novichkova Iu N, Zubkova L V, Ter-Gevondian N M, Nenakhova T V
出版信息
Klin Med (Mosk). 1991 Nov;69(11):40-3.
PMID:1808404
Abstract
摘要
相似文献
1
[A new peripheral vasodilator prostaglandin E1 in atherosclerosis of lower limb vessels and Raynaud disease].
Klin Med (Mosk). 1991 Nov;69(11):40-3.
2
Recount of prostaglandin E1 therapy in a patient with Raynaud's phenomenon.
J Am Osteopath Assoc. 1995 Oct;95(10):572.
3
[Prostaglandin E1 in the treatment of chronic ischemia of the extremities].
Pol Arch Med Wewn. 1990 Nov;84(5):321-7.
4
Treatment of peripheral arterial insufficiency with inositoli nicotinas (Hexanicit).
Scand J Clin Lab Invest Suppl. 1967;99:226-32.
5
[Prostaglandin E1 in treatment of incomplete ischemia syndromes of the lower extremity].
Vasa Suppl. 1991;32:377-82.
6
[Effect of surheme on improved blood flow in limbs].
Wiad Lek. 1972 Jul 15;25(14):1297-300.
7
8
9
The use of Hexanicotol (inositol niacinate) in peripheral vascular disease.
Del Med J. 1967 Feb;39(2):33-8.
10
EDTA chelation as a treatment of arteriosclerosis.
N Z Med J. 1990 Apr 11;103(887):162-3.
引用本文的文献
1
Vasodilators for primary Raynaud's phenomenon.用于原发性雷诺现象的血管扩张剂。
Cochrane Database Syst Rev. 2021 May 17;5(5):CD006687. doi: 10.1002/14651858.CD006687.pub4.
Zotero 插件